Antiparkinson Drugs

2018 ◽  
pp. 200-200
Author(s):  
Mathew George ◽  
Lincy Joseph ◽  
Sujith K
Keyword(s):  
Antiparkinson Drugs

A pharmacoepidemiological study of the consumption of antiparkinson drugs in the Basque Autonomous Community (Spain) (1992–2004)

2007 ◽  
Vol 13 (8) ◽  
pp. 500-504 ◽  
Author(s):  
Eider Abasolo Osinaga ◽  
Luis Carlos Abecia Inchaurregui ◽  
Itziar Etxeandia Ikobaltzeta ◽  
Natalia Burgos Alonso ◽  
Javier García del Pozo
Keyword(s):  
Autonomous Community ◽  
Pharmacoepidemiological Study ◽  
Antiparkinson Drugs

Pharmacology: Anti-nicotinic Properties of Anticholinergic Antiparkinson Drugs

1998 ◽  
Vol 50 (11) ◽  
pp. 1299-1305 ◽  
Author(s):  
Z. G. GAO ◽  
B. Y. LIU ◽  
W. Y. CUI ◽  
L. J. LI ◽  
Q. H. FAN ◽  
...  
Keyword(s):  
Antiparkinson Drugs

scholarly journals Anticholinergic Poisoning with Antipsychotic and Antiparkinson Drugs: Case Report

2015 ◽  
Vol 23 (1) ◽  
pp. 1-4
Author(s):  
Mehtap HONCA ◽  
Aslı KARAOSMAN MEMET ◽  
Eyüp HORASANLI
Keyword(s):  
Case Report ◽  
Antiparkinson Drugs

scholarly journals Limitations of Long Term Use of Antiparkinson Drugs

1984 ◽  
Vol 11 (S1) ◽  
pp. 191-194 ◽  
Author(s):  
Melvin D. Yahr
Keyword(s):  
Considerable Extent ◽  
Effective Control ◽  
Therapeutic Effects ◽  
Dopaminergic Agents ◽  
Number Of Patients ◽  
Antiparkinson Drugs ◽  
Nature Frequency

ABSTRACTEffective control of parkinsonian symptoms can be achieved in a substantial number of patients by the judicious use of dopaminergic agents. To a considerable extent these drugs produce optimal therapeutic effects during the first 3–5 years of their use. Subsequently, efficacy diminishes with reemergence of parkinsonian symptoms as well as a number of untoward responses. The nature, frequency and mechanisms underlying the limitations of long term use of presently available anti-parkinson agents are discussed in this presentation.

The Site of Action of Antiparkinson Drugs

1955 ◽  
Vol 15 (4) ◽  
pp. 209-224 ◽  
Author(s):  
Franco Rinaldi ◽  
Harold E. Himwich
Keyword(s):  
Antiparkinson Drugs ◽  
Site Of Action
Sign in / Sign up

Export Citation Format

Share Document